The Prix Galien Africa rewards excellence and innovation. It is awarded for products, services and initiatives that are highly convincing or promising in the field of innovative discoveries and therapies for the benefit of humanity.
It is intended to reward researchers, institutions and pharmaceutical industries from the public or private sector that have developed initiatives, services, pharmaceutical, biotechnological, herbal medicine, diagnostic products and medical devices recently introduced on the African market.
In keeping with the spirit of the Prix Galien Africa’s mission, one special distinction may be awarded per edition. It may be proposed by the Jury to the Honorary Committee and whose criteria are defined by the Jury.
Pharmaceuticals, biotechnology, phytotherapy, diagnostics, medical devices and digital solutions must be based on innovative science, or developed through synthetic chemistry or molecular biology or made naturally with plants according to specific criteria, specifications, tested in controlled clinical trials and marketed by ethical pharmaceutical companies.
The product or device initial marketing authorization (MA) must be valid for a maximum of five years as of December 31 of the competition year.